Synko Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 41.61%
(FY 2022)
- Profit 2966.38%
(FY 2022)
- Ebitda -985.04%
(FY 2022)
- Net Worth 117.46%
(FY 2022)
- Total Assets 38.33%
(FY 2022)
About Synko Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Synko Healthcare Private Limited India is Sumit Walia as CEO. Bimlesh Walia and Darpan Kataria serve as directors at the Company.
- CIN/LLPIN
U33208DL2018PTC331950
- Company No.
331950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2018
- Date of AGM
26 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Synko Healthcare Private Limited offer?
Synko Healthcare Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Anaemia Medicine, Anti Infective Drugs & Medicines, Antiviral Drugs, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Injectable Products, Pharmaceutical Tablets.
Who are the key members and board of directors at Synko Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Walia | CEO | 01-Apr-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darpan Kataria  | Director | 04-Apr-2018 | Current |
| Bimlesh Walia | Director | 04-Apr-2018 | Current |
Financial Performance of Synko Healthcare.
Synko Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.61% increase. The company also saw a substantial improvement in profitability, with a 2966.38% increase in profit. The company's net worth Soared by an impressive increase of 117.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synko Healthcare?
Unlock access to Synko Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synko Healthcare?
Unlock and access historical data on people associated with Synko Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synko Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synko Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
